CL2007003211A1 - Uso de tenecteplasa para reestablecer la funcion de un cateter disfuncional para hemodialisis permanente en un mamifero. - Google Patents
Uso de tenecteplasa para reestablecer la funcion de un cateter disfuncional para hemodialisis permanente en un mamifero.Info
- Publication number
- CL2007003211A1 CL2007003211A1 CL200703211A CL2007003211A CL2007003211A1 CL 2007003211 A1 CL2007003211 A1 CL 2007003211A1 CL 200703211 A CL200703211 A CL 200703211A CL 2007003211 A CL2007003211 A CL 2007003211A CL 2007003211 A1 CL2007003211 A1 CL 2007003211A1
- Authority
- CL
- Chile
- Prior art keywords
- tenecteplasa
- hemodialisis
- mammer
- dysfunctional
- catheter
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
- C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
- A61L2300/254—Enzymes, proenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
- A61M1/285—Catheters therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M2025/0019—Cleaning catheters or the like, e.g. for reuse of the device, for avoiding replacement
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86475806P | 2006-11-07 | 2006-11-07 | |
US98348907P | 2007-10-29 | 2007-10-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2007003211A1 true CL2007003211A1 (es) | 2008-05-30 |
Family
ID=39362326
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL200703211A CL2007003211A1 (es) | 2006-11-07 | 2007-11-07 | Uso de tenecteplasa para reestablecer la funcion de un cateter disfuncional para hemodialisis permanente en un mamifero. |
Country Status (10)
Country | Link |
---|---|
US (1) | US8916148B2 (es) |
EP (1) | EP2086571A2 (es) |
JP (1) | JP5871449B2 (es) |
AR (1) | AR063603A1 (es) |
CA (1) | CA2668347C (es) |
CL (1) | CL2007003211A1 (es) |
PE (2) | PE20081488A1 (es) |
TW (1) | TW200826981A (es) |
UY (1) | UY30693A1 (es) |
WO (1) | WO2008070353A2 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL371760A1 (en) | 2001-11-26 | 2005-06-27 | Genentech, Inc. | Catheter composition and uses thereof |
US20070014779A1 (en) * | 2002-11-14 | 2007-01-18 | Genentech, Inc. | Plasminogen activator variant formulations |
CA2668347C (en) | 2006-11-07 | 2017-06-20 | Genentech, Inc. | Tissue plasminogen activator variant uses |
DK2654770T3 (en) | 2010-12-23 | 2018-10-29 | Gennova Biopharmaceuticals Ltd | PHARMACEUTICAL COMPOSITIONS OF TENECTEPLACE |
PE20171131A1 (es) | 2014-10-21 | 2017-08-09 | Gennova Biopharmaceuticals Ltd | Proceso novedoso de purificacion para el aislamiento y produccion comercial de tnk-tpa recombinante (tenecteplasa) |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI831484L (fi) | 1982-05-05 | 1983-11-06 | Genentech Inc | Plasminogen aktivator foer maenskovaevnad |
US5000185A (en) | 1986-02-28 | 1991-03-19 | Cardiovascular Imaging Systems, Inc. | Method for intravascular two-dimensional ultrasonography and recanalization |
US5019096A (en) | 1988-02-11 | 1991-05-28 | Trustees Of Columbia University In The City Of New York | Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same |
US5270198A (en) | 1988-05-20 | 1993-12-14 | Genentech, Inc. | DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells |
GB8820945D0 (en) | 1988-09-07 | 1988-10-05 | Smith & Nephew | Medical articles |
NZ230808A (en) | 1988-10-24 | 1993-04-28 | Squibb & Sons Inc | Pharmaceutical compositions and combinations containing an angiotensin-converting enzyme inhibitor and a thrombolytic agent |
WO1991017724A1 (en) | 1990-05-17 | 1991-11-28 | Harbor Medical Devices, Inc. | Medical device polymer |
US5399158A (en) | 1990-05-31 | 1995-03-21 | The United States Of America As Represented By The Secretary Of The Army | Method of lysing thrombi |
US5363754A (en) | 1991-09-03 | 1994-11-15 | Grainco Queensland Co-Operative Association Limited | Apparatus for preparing animal feedstuff from cotton seed |
AU664469B2 (en) | 1992-06-03 | 1995-11-16 | Genentech Inc. | Tissue plasminogen activator glycosylation variants with improved therapeutic properties |
US5688516A (en) | 1992-11-12 | 1997-11-18 | Board Of Regents, The University Of Texas System | Non-glycopeptide antimicrobial agents in combination with an anticoagulant, an antithrombotic or a chelating agent, and their uses in, for example, the preparation of medical devices |
US5362754A (en) | 1992-11-12 | 1994-11-08 | Univ. Of Tx Md Anderson Cancer Center | M-EDTA pharmaceutical preparations and uses thereof |
US5849736A (en) | 1993-11-24 | 1998-12-15 | The Dupont Merck Pharmaceutical Company | Isoxazoline and isoxazole fibrinogen receptor antagonists |
BR9408137A (pt) | 1993-11-24 | 1997-08-12 | Du Pont Merck Pharma | Composto éster de prodroga método de tratamento composição farmacêutica e método de inibição |
US5885967A (en) | 1994-03-04 | 1999-03-23 | Eli Lilly And Company | Antithrombotic agents |
US5509896A (en) | 1994-09-09 | 1996-04-23 | Coraje, Inc. | Enhancement of thrombolysis with external ultrasound |
US5556380A (en) | 1995-04-05 | 1996-09-17 | Duke University | Method for removing fibrin sheaths from catheters |
AU716005B2 (en) | 1995-06-07 | 2000-02-17 | Cook Medical Technologies Llc | Implantable medical device |
US5772640A (en) | 1996-01-05 | 1998-06-30 | The Trustees Of Columbia University Of The City Of New York | Triclosan-containing medical devices |
US5932299A (en) | 1996-04-23 | 1999-08-03 | Katoot; Mohammad W. | Method for modifying the surface of an object |
US5840733A (en) | 1996-07-01 | 1998-11-24 | Redcell, Canada, Inc. | Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes |
US5837688A (en) | 1996-11-27 | 1998-11-17 | Gelfand; Mathew I. | Use of thrombolytic reagents for prevention of vascular disease |
AU5526098A (en) | 1996-12-23 | 1998-07-17 | Biochem Pharma Inc. | Bicyclic thrombin inhibitors |
GB9626795D0 (en) | 1996-12-23 | 1997-02-12 | Geistlich Soehne Ag | Combating infection in delivery systems |
US5981826A (en) | 1997-05-05 | 1999-11-09 | Georgia Tech Research Corporation | Poly(vinyl alcohol) cryogel |
JPH10328293A (ja) | 1997-06-04 | 1998-12-15 | Unitika Ltd | 医療用具及びその製造方法 |
US6206914B1 (en) | 1998-04-30 | 2001-03-27 | Medtronic, Inc. | Implantable system with drug-eluting cells for on-demand local drug delivery |
US6166007A (en) | 1998-07-02 | 2000-12-26 | Sodemann; Klaus | Antimicrobial locks comprising taurinamide derivatives and carboxylic acids and/or salts thereof |
US6174537B1 (en) | 1998-09-25 | 2001-01-16 | Becton, Dickinson And Company | Catheter flush solution and method for its use |
AR022909A1 (es) | 1999-03-11 | 2002-09-04 | Du Pont Pharm Co | Sinergia entre heparina de bajo peso molecular e inhibidores de la agregacion plaquetaria, que provee una terapia combinada para la prevencion ytratamiento de diversas afecciones tromboembolicas |
JP2002538226A (ja) | 1999-03-11 | 2002-11-12 | デュポン ファーマシューティカルズ カンパニー | Xa因子阻害剤およびアスピリン、組織プラスミノーゲンアクチベータ(TPA)、GPIIb/IIIa拮抗剤、低分子量ヘパリンまたはヘパリンの組合せ使用による血栓症の治療 |
CA2302720C (en) | 1999-03-29 | 2009-07-14 | Ed Geistlich Sohne Ag Fur Chemische Industrie | Anticoagulant/sterilizing compositions and methods |
US6187768B1 (en) | 1999-06-01 | 2001-02-13 | Becton, Dickinson And Company | Kit for flushing medical devices and method of preparation |
EP1060747A3 (en) | 1999-06-16 | 2001-12-05 | New York Blood Center, Inc. | Fibrin(ogen) degradation and clot lysis by fibrinolytic metalloproteinase |
US6592564B2 (en) | 1999-07-23 | 2003-07-15 | Vasca, Inc. | Methods and kits for locking and disinfecting implanted catheters |
US6350251B1 (en) | 2000-01-18 | 2002-02-26 | Biolink Corporation | Biocidal locks |
US20010031981A1 (en) | 2000-03-31 | 2001-10-18 | Evans Michael A. | Method and device for locating guidewire and treating chronic total occlusions |
EP1284780B1 (en) | 2000-05-10 | 2008-05-07 | Ash Access Technology, Inc. | A catheter lock solution including a photo-oxidant |
CA2420182A1 (en) | 2000-08-25 | 2002-03-07 | Organ Recovery Systems, Inc. | Methods of thrombolytic organ treatment and repair |
US20050215978A1 (en) | 2001-05-25 | 2005-09-29 | Ash Stephen R | Method of enhancing catheter patency using a citrate salt catheter lock solution |
PL371760A1 (en) * | 2001-11-26 | 2005-06-27 | Genentech, Inc. | Catheter composition and uses thereof |
US20070014779A1 (en) | 2002-11-14 | 2007-01-18 | Genentech, Inc. | Plasminogen activator variant formulations |
EP1442753B1 (en) * | 2003-02-03 | 2007-02-21 | Polaschegg, Hans-Dietrich, Dr.techn. | Composition for the prevention of indwelling device related infection |
US7696182B2 (en) * | 2004-11-02 | 2010-04-13 | Nd Partners, Llc | Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin |
US7749529B2 (en) * | 2005-02-08 | 2010-07-06 | Ash Access Technology, Inc. | Catheter lock solution comprising citrate and a paraben |
CA2668347C (en) | 2006-11-07 | 2017-06-20 | Genentech, Inc. | Tissue plasminogen activator variant uses |
-
2007
- 2007-10-30 CA CA2668347A patent/CA2668347C/en active Active
- 2007-10-30 WO PCT/US2007/082933 patent/WO2008070353A2/en active Application Filing
- 2007-10-30 JP JP2009535417A patent/JP5871449B2/ja active Active
- 2007-10-30 EP EP07871279A patent/EP2086571A2/en not_active Ceased
- 2007-10-30 US US12/447,838 patent/US8916148B2/en active Active
- 2007-11-06 PE PE2007001525A patent/PE20081488A1/es not_active Application Discontinuation
- 2007-11-06 PE PE2011001779A patent/PE20120639A1/es not_active Application Discontinuation
- 2007-11-07 AR ARP070104960A patent/AR063603A1/es not_active Application Discontinuation
- 2007-11-07 TW TW096142107A patent/TW200826981A/zh unknown
- 2007-11-07 CL CL200703211A patent/CL2007003211A1/es unknown
- 2007-11-07 UY UY30693A patent/UY30693A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2008070353A3 (en) | 2008-08-28 |
JP5871449B2 (ja) | 2016-03-01 |
PE20081488A1 (es) | 2008-10-30 |
CA2668347C (en) | 2017-06-20 |
AR063603A1 (es) | 2009-02-04 |
PE20120639A1 (es) | 2012-05-26 |
EP2086571A2 (en) | 2009-08-12 |
WO2008070353A2 (en) | 2008-06-12 |
UY30693A1 (es) | 2008-05-02 |
CA2668347A1 (en) | 2008-06-12 |
US20120270299A1 (en) | 2012-10-25 |
TW200826981A (en) | 2008-07-01 |
JP2010509229A (ja) | 2010-03-25 |
US8916148B2 (en) | 2014-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0821668A2 (pt) | Uso | |
DE602007000122D1 (de) | Feststoffbatterie | |
BRPI0807453A2 (pt) | Preparação sólida | |
DE502006009368D1 (de) | Zwitterionische strukturelemente aufweisende partikel | |
BRPI0716327A2 (pt) | Composto de fenilpropionamida e uso | |
CR10725A (es) | Compuestos de pirazolina y su uso y composiones farmaceuticas | |
BRPI0808246A2 (pt) | "fralda descartável". | |
DK1954301T3 (da) | Konfekture-sammensætninger med magnolia-barkekstrakt | |
SE0702067L (sv) | Bestick | |
FR2908109B1 (fr) | Element de nacelle de turboreacteur | |
BRPI0807989A2 (pt) | Composto de éster e uso do mesmo. | |
DE602007001744D1 (de) | Uhr | |
CL2007003211A1 (es) | Uso de tenecteplasa para reestablecer la funcion de un cateter disfuncional para hemodialisis permanente en un mamifero. | |
DE602006016553D1 (de) | Umkehrbare Uhr | |
DE502007005032D1 (de) | Der Astromischer | |
NL1033745A1 (nl) | Sleepboot. | |
FR2904415B3 (fr) | Cuillere de dosage. | |
ATE530164T1 (de) | Wässrige pharmazeutische zubereitung | |
BRPI0823049A2 (pt) | Anticorpos para glicoesfingolipídeos tipo 1 anti-estendidos, derivados dos mesmos e uso. | |
BRPI0812535A2 (pt) | derivado de 17beta-ciano-19-androst-4-eno, seu uso e medicamentos compreendendo o derivado | |
FIU20070173U0 (fi) | Tuntoelin | |
FR2905824B1 (fr) | Plaque de preparation culinaire. | |
DE112006002119A5 (de) | Tee-Eindrücker | |
ITMI20060730A1 (it) | Friggitrice | |
DE112007002444A5 (de) | Fluiddosiervorrichtung |